NITRATE REDUCTASE AS MARKER FOR FILAMENTOUS FUNGI

Abstract: The invention relates to use of the nitrate reductase gene as a selection marker in transformations of the antibiotic-producing species Penicillium chrysogenum and Acremonium chrysogenum. In particular it relates to a process for obtaining cells of Penicillium chrysogenum or Acremonium chrysogenum capable of expressing nitrate reductase from cells of the same species which are initially deficient in expression of the nitrate reductase gene (niaD-cells), which comprises introducing into said niaD-cells vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the selected host cells, followed by selection of cells thus transformed by their ability to grow on a suitable medium containing nitrate as the only source of nitrogen and to vector DNA for use in such a process.

Description: Nitrate reductase as marker for filamentous fungi The present invention relates to the novel use of a marker system in the transformation of filamentous fungi. In particular it relates to the use of the nitrate reductase gene as a selection marker in transformations of the antibiotic-producing species Penicillium chrysogenum and Acremonium chrysogenum. c The development and exploitation of recombinant DNA technology in filamentous fungi has been slow, in part because of the lack of efficient and industrially usable systems for readily selecting those cells which have been transformed with the desired vector DNA. Transformation and hence stable inclusion of the desired DNA into the ■ ] DMA seguence of the fungal cell is a rare event and thus such a selection system for determining those few cells, perhaps among millions of untransformed cells, which have acguired the desired DNA is a necessity. Various systems have been proposed using the presence of a marker gene in the vector along with the desired DNA, by which the ^5 transformed cells can be recognised and selected. Thus selection of successfully transformed cells of filamentous fungi has previously been demonstrated with, for example, the acetamidase (amdS) gene which confers upon transformants the ability to utilise acetamide as the sole source of nitrogen [see for instance 20 Kelly &. Hynes, EMBO 3, 4, p475 (1985)] and hence provides a method of identifying such transformants. A characteristic of filamentous fungal transformation is a low efficiency of transformation, since exogenous DNA is not readily and stably integrated into the host genome. This results in a high background level of non-transformants and, in the 25 case of the amdS selection marker system, it has been found that some of these non-transformants will also grow on acetamide as the sole nitrogen source, even though they are deficient in the expression of the acetamidase gene. This makes the amdS marker selection system 30 difficult to operate, particularly where there is a low efficiency.of transformation, since it does not clearly distinguish those cells which have undergone transformation. This problem has been to some extent overcome by the development of antibiotic selection as a marker method. For example, SUBSTITUTE SHEET transformation with a vector which includes a phosphotransferase gene as a marker confers upon the transformants resistance to the aminoglycosidic antibiotics G418 and hygro ycin B [see for instance Punt et j_l, Gene, 56, pll7 (1987)]. Transformed cells may then be recognised by their ability to grow on a medium containing one or other of these antibiotics. Although this system provides a clear-cut method of selecting transformants, the use of the resultant antibiotic resistant fungal strains on a large industrial scale is undesirable since it requires a high degree of containment making industrial exploitation both difficult and expensive. Furthermore, it is considered desirable in the use of such strains to maintain a selection pressure by the presence of antibiotic in the fermentation medium, in order to prevent growth of revertants where the integrated genes are not stably maintained; such continuous use of antibiotic in the fermentation medium is, of course, disadvantageous. Other marker systems for filamentous fungi have been described, such as the reversions of arginine auxotrophy using the argB gene [Buxton et al, Gene, 37, p207 (1985)], tryptophan C auxotrophy using the trpC gene [Sanchez et al, Gene 51, p97 (1987)] or uracil auxotrophy using the pyr-4 or pyrG genes [Cantoral _ej_ j_l, Biotechnology, 5, p494 (1987)]. These techniques, however, require complicated and lengthy procedures involving mutation and selection to obtain suitable auxotrophic mutants. Also such procedures often lead to a loss of antibiotic productivity in antibiotic producing strains of filamentous fungi. There is a need, therefore, to develop a marker system for the identification of transformed filamentous fungi where isolation of suitable mutants which are deficient in the expression of the marker gene is straightforward and selection procedures provide clear and ready identification of the transformed cells without the use " of antibiotic resistance markers. Furthermore, such a system will ideally involve the use of a homologous gene as the marker gene (i.e. a gene from the same species as that being transformed); in the case of a homologous gene as the marker gene, expression and transformation frequency are likely to be optimised since the genetic code will be native to the transformed host and hence more readily recognised by the SUBSTITUTE SHEET host cell, leading to more efficient expression of the gene. Also, it is preferable to avoid introduction of foreign genes into a host filamentous fungus so as to reduce any environmental risks. We have now found that transformed cells of the antibiotic producing filamentous fungi Penicillium chrysogenum and Acremonium chrysogenum may be successfully and efficiently selected by the use of a nitrate reductase marker gene in the transformation of cells deficient in nitrate reductase. Such a system provides clear-cut selection of transformants, avoids the disadvantages of the insertion of antibiotic resistance and allows, if desired, the use of a homologous gene as the marker gene. Thus in one aspect of the present invention, we provide a process for obtaining cells of Penicillium chrysogenum or Acremonium chrysogenum capable of expressing nitrate reductase from cells of the same species which are initially deficient in expression of the nitrate reductase gene (nia D ~ cells), which comprises introducing into said nia D~ cells vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the selected host cells, followed by selection of cells thus transformed by their ability to grow on a suitable medium containing nitrate as the only source of nitrogen. Strains of Penicillium chrysogenum and Acremonium chrysooenurn (formerly known as Cephalosporium acremonium) which may be used in the process of the invention are preferably antibiotic producing strains or nitrate reductase deficient mutants thereof. Strains of __ chrysogenum are widely used in the industrial production of penicillin antibiotics such as penicillin G and penicillin V. Similarly, strains of A. chrysogenum are used in the production of cephalosporin antibiotics such as cephalosporin C, deacetylcephalosporin C and deacetoxycephalosporin C. The biosynthesis of both penicillins and cephalosporins begins with the condensation of three amino acids, L-α-aminoadipic acid, L-cysteine and L-valine by the enzyme ACV synthetase. The tripeptide which is formed is cyclised by the enzyme isopenicillin N synthetase to produce isopenicillin N. In P. chrysogenum isopenicillin N is converted to a number of derivatives of 6-aminopenicillanic acid including, for example, the phenylacet±c acid derivative, penicillin G, and the phenoxyacetic acid derivative, SU B STI TUTESHEE T penicillin V. In A. chrysogenum isopenicillin N undergoes modification by the enzyme deacetoxycephalosporin C synthetase (also known as expandase) which converts the thiazolidine ring of the penam structure into the dihydrothiazine ring of the cephem structure, to give deacetoxycephalosporin C. This is converted by the enzyme deacetylcephalosporin C synthetase (also known as hydroxylase) to deacetylcephalosporin C. (In A. chrysogenum the expandase and hydroxylase enzyme activities are located on the same protein molecule). The deacetylcephalosporin C is then acetylated by the 10 enzyme DAC acεtyltransferase to cephalosporin C. The vector DNA which is integrated into the fungal genome in the process of the invention preferably includes, as well as the marker gene coding for nitrate reductase, at least one industrially important gene which will result in an improved strain following transformation. Thus the gene to be introduced may be, for example, one which will ■ jc improve the productivity or cost effectiveness of antibiotic fermentation and hence may be, for instance, a gene involved in the biosynthetic pathwβy of penicillins or cephalosporins, a regulatory gene involved in the productive phase of growth of the organism, a gene which allows growth of the organism on a novel substrate or a gene - Q which will change the metabolite produced. Genes which may be inserted include a gene coding for the enzymes ACV synthetase, isopenicillin synthetase, deacetoxycephalosporin C synthetase or DAC acεtyltransferase. For the reasons discussed above, these genes are preferably isolated from the same species as that being transformed. 25 In an alternative procedure according to the process of the invention, the gene which it is desired to insert into the fungal genome and the nitrate reductase marker gene may be located on different vectors, since there is considerable likelihood that a host strain transformed by the vector containing the selectable marker will 30 also have been transformed by the desired gene, even when they are located on separate vectors. The transformed strain prepared by the procedure of the invention will possess either a new gene or multiple copies of one of its existing genes such as a biosynthesis pathway gene and will thus 35 have operational advantages for the production of penicillins or SUBSTITUTESHEET cephalosporins compared with the parental strain. Examples of such advantages include improved growth rate or titre of the penicillin or cephalosporin; improved stability; improved growth characteristics on different media; and improved ease of extraction of the products. The desired genes which are integrated into the fungal genome according to the process of the invention may be prepared by conventional techniques known in the art, or using a method analogous to that described herein for the nitrate reductase gene. Suitable host cells of P. chrysogenum and A. chrysogenum to be transformed by the process of the invention are strains deficient in the expression of the nitrate reductase structural gene (niaD). They are therefore unable to utilise nitrate as a source of nitrogen and hence are unable to grow on a minimal medium where nitrate is the sole nitrogen source. Such deficient strains are thus readily distinguished from strains transformed by the process of the invention which have a nitrate reductase gene as a selectable marker. Nitrate reductase deficient strains may arise with low frequency by spontaneous mutation. Alternatively, mutation may be induced by standard mutagenesis technigues. Such techniques include chemical mutagenesis working at the DNA level, for example, 5-bromo- uracil and 2-aminopurine may be incorporated into the DNA sequence during DNA replication in place of thymidine and adenine, respectively, causing miscopying errors- Chemical modification of nucleotides may alter pairing in the DNA, for example, nitrous acid may deaminate adenine, cytosine and guanine, and hydroxylamine specifically attacks cytosine (to form N-6-hydroxycytidine) which pairs with adenine instead of guanine. Alkylating agents, for example, sulphur or nitrogen mustards, ethylene oxides, ethylenemethanesulphonate and N-methyl-N'- nitro-N-nitrosoguanidine (NTG) act on guanine residues and may cause base pair deletions. Chromosomal abberations may be caused by ionising radiation such as alpha, beta and gamma rays or X-rays, or non-ionising radiation such as ultra-violet light. A variety of other chemical mutagenic compounds may also be used including diepoxides, 8- ethoxycaffeine and maleichydrazine. SUBSTITUTESHEET Nitrate reductase deficient mutant strains may readily be identified on a medium containing chlorate (for example, 400mM sodium chlorate) and a non-nitrate reductase suppressing nitrogen source (such as lOmM glutamate), since strains able to produce the nitrate reductase enzyme will reduce the chlorate to chlorite which is toxic and will kill the cells. Simple growth tests on a variety of nitrogen sources can then readily be used to distinguish nitrate reductase deficient mutants from other chlorate resistant mutants [see for instance Birkett & Rowlands, 3. Gen. Hicrobiol., 123, p281 (1981)]. After selection on the chlorate medium, isolated mutants may also be tested for reversion of the mutation or for any loss of antibiotic titre by, for example, shake flask analysis. Transformation of nitrate reductase deficient strains of P. chrysogenum and A. chrysogenum with a nitrate reductase marker gene will restore to the strain the ability to utilise nitrate as the sole nitrogen source. The nitrate reductase gene to be used as the transformation marker can be isolated from a genomic DNA library of a strain of filamentous fungus. Preferably the strain will be of the same species as the intended host strain or from a strain of a related species. Thus, as well as P.chrysogenum and A.chrysogenum, strains of Aspergillus species such as Aspergillus nidulans , Aspergillus niger and Aspergillus oryzae may be used. The genomic library may be constructed by partial digestion of the total chromosomal DNA using a restriction enzyme, for example, Sau 3A1 [see for instance Garber ά Yoder, Anal. Biochem., 135, p416 (1983)]. Digestion fragments in the range of 15-25kbp are conveniently recovered for example, by size fractionation on a sucrose gradient. The digestion fragments may be ligated into a phage vector such as λEMBL3 or XEHBL4. These may then be packaged _in_ vitro into phage particles which may then be propagated in a prokaryatic host such as E. coli to create a phage library. This library may be screened following plating of the phage particles on a bacterial lawn by using either all, or a fragment, of a niaD gene isolated from another filamentous fungus such as a species of Asperαillus spp.. SUBSTITUTE SHEET Alternatively, the library may be screened for expression of nitrate reductase activity using an expression system known in the art or one analogous to the process described herein. DNA sequences which are selected by this method may themselves be used as probes to select other DNA sequences coding for the nitrate reductase enzyme. Their c effectiveness as a marker gene may be demonstrated by their use in an appropriate reco binant DNA molecule to transform nitrate reductase deficient strains of either P. chrysogenum or A. chrysogenum. The isolated DNA sequence coding for the nitrate reductase enzyme is preferably derived from the same species as that being transformed. I Q In the process of the invention, nitrate reductase deficient hosts are transformed with the nitrate reductase marker gene and the desired gene which are ligated into an expression vector. The expression vector is preferably one which exhibits high transformation freguency in the host strain and must be so constructed that the coding nι- elements of the desired gene to be integrated into the genome, and the nitrate reductase marker gene, are efficiently expressed once transformed into the host. The expression vector should be capable of replication in a prokaryotic host, preferably Escherichia coli, to facilitate further 2o genetic manipulation. Following multiplication of E. coli, vectors containing the niaD can be readily identified using hybridisation selection, by homology to niaD genes from other related species. Where the desired gene to be incorporated into the fungal genome is incorporated in the same expression vector as the marker 2 gene, the desired gene should be ligated into the vector in such a way that both genes are expressed, that is the ligation does not disrupt the functional activity of the nitrate reductase gene or those genes necessary for replication and selection of the prokaryotic host. This may be achieved by ensuring that the vector possesses a unique •? 0 restriction site into which the desired gene may be inserted. Suitable expression vectors for the transformation of the nitrate reductase deficient host may consist of segments of chromosomal, non-chromosomal and synthetic DNA sequences, such as SU β βT ITUTE SHEET derivatives of known bacterial plasmids, for example, "natural" plasmids such as Col El or "artificial" plasmids such as pBR322 or pMB9, or yeast plasmids, for example, 2μ. Other suitable vectors may be phage DNA's, for example, derivatives of M13, or bacteriophage lambda, or yeast vectors such as derivatives of YIp, YEp or YRp. Such expression vectors may also be characterised by at least one expression control sequence which is operatively linked to the nitrate reductase marker gene and the desired gene. Examples of useful expression control sequences include the glycolytic promoters of yeast (e.g. the promoter for 3-phosphoglycerate kinase, PGK), the promoters of yeast acid phosphatase (e.g. Pho 5) or the alcohol dehydrogenase-2 (alcA) or glucoamylase promoter. Preferably, the control sequence is isolated with the marker gene or the desired gene thus avoiding the need to construct the expression vector using foreign control sequences. The expression vector may also optionally be characterised by an autonomous replication sequence (ars) derived from a fragment of either mitochondrial or chromosomal DNA, preferably from the same species as that being transformed. In order to transform the nitrate reductase deficient host cells according to the process of the invention, the cells may first be converted to protoplasts or, alternatively treated with a metal salt such as lithium acetate as described, for example, by Dhawale et al, Current Genetics, 8, p77 (1984). Other method of transformation well known in the art include electroporation or liposome-enclosed DNA treatment of protoplasts, microinjection, and alternative physical means of introducing DNA into fungal cells. The preferred method utilises protoplasts. Prior to their formation, the host strain is cultured to a suitable population size in a conventional manner, for example, in shake flasks. The nature of the culture medium can influence the protoplast yield but will generally be conventional for the growth of P. chrysogenum or A. chrysogenum with, of course, the addition of an alternative nitrogen source to nitrate such as glutamate. Also, the maximum yield of protoplasts is obtained from the mycelium of the mutant strain during the phase of active growth. The mycelium is then recovered by filtration or centrifugation and washed to remove the culture medium. The recovered mycelium may optionally be treated with an agent to maintain thiols in a reduced SUB STI TUTE S HEET state (for example dithiothreitol, 0.005M to 0.1M at pH5 to pH8.5) to assist protoplast production and hence improve the yield. The mycelium is then treated with one or more enzyme preparations in the presence of a suitable buffer to maintain the pH and osmotic pressure of the medium. Suitable enzyme preparations are commercially available, such as Novozy 234 or Novozy 249 (Novo, Industri, A/S DK 2880 Bagsvaerd, Denmark). These preparations are undefined mixtures containing several enzymes such as cellulose, protease, chitinase and pectinase. The mycelium is incubated with the enzyme preparation until a satisfactory yield of protoplasts is obtained. The pH and temperature of the incubation medium should be selected in accordance with the directions for the enzyme used, for example, at about pH 5.8 and 26°C for about 3 hours in the case of Novozym 234. Typical enzyme concentrations are in the range 0.05-20mg/ml, for example, 5mg/ml for Novozym 234. A suitable buffer is, for example, 20mM phosphate buffer, pH 5.8. The osmotic pressure of the incubation medium should be maintained in a range to ensure stability of the protoplasts, for example, equivalent to 0.5M to 1.0M. The osmotic pressure may be adjusted using inorganic salts, for example, potassium chloride or magnesium sulphate, or with sugar or a sugar alcohol. The protoplasts may be separated from the mycelial debris by filtration through a sintered glass funnel or cotton wool and/or by centrifugation, for example, at 3000-4000 rpm for 10 to 20 minutes. The protoplasts are recovered as a pellet which should be washed in the osmotic stabilising solution (for example, 0.7M potassium chloride) before resuspending the protoplasts in an osmotically stabilised solution at a concentration of between 10* 4 and 10 8 protoplasts/ml. Transformation of the isolated protoplasts is effected using the vectors described above in a ratio of about 10-20μg of vector DNA per 10 8 protoplasts. In order to maximise the probability of transformation, polyethylene glycol (PEG) is added. Preferably, the PEG has a molecular weight in the range 1000-8000, for example, about 4000. The PEG is employed as a solution in an aqueous buffer, preferably at a concentration of 20-60%, for example 50%. The pH is SUBSTITUTE SH T suitably in the range 5-10, preferably between pH 5.8 and 7.5. The process is preferably assisted by calcium ions at a concentration in the range 0.002M to 1.0M, for example, using 0.05M calcium chloride. The transformation conveniently takes place at a temperature in the range of 0 to 25°C, preferably at room temperature for up to 1 hour. Incubation may be repeated following further addition of PEG. Tranformation frequency may be improved by conducting the first incubation on ice. Also warming the transformation mixture in a water bath (about 35°C) prior to the second incubation may improve the transformation frequency. The protoplasts may be harvested by mild centrifugation (for example, at 2000 rpm for 5 to 10 minutes) and resuspended in a little suitable osmotically stable buffer (for example, a few ml of 1.0M sorbitol). Selection of transformants is readily achieved by plating fungal cells, which have undergone the transformation procedure, on a transformation selection medium. Such a medium should be minimal medium in which the sole nitrogen source is nitrate, such as metal nitrate salts, for example, sodium nitrate. If necessary, for instance, when protoplast transformation has taken place the medium should have a high osmotic strength to allow protoplast regeneration, for example, 11% sucrose. Incubation at between 10 and 30°C for between 5 and 20 days is required for the transformant colonies to grow strongly out of any non-nitrate utilising background growth. Our preferred method for transforming a nitrate reductase deficient host strain of P. chrysogenum or A. chrysogenum according to the process of the invention comprises the steps of :- (i) digestion of the total DNA isolated from cells of the same species as the intended host or a fungus of a related species, with one or more restriction enzymes, such as the enzyme 5au3Al; (ii) preparation of bacteriophage vectors known to be capable of infection of, and replication in, a chosen prokaryote, preferably Escherichia coli, fused with the restriction fragments obtained in (i); SUBSTITUTESHEET (iii) In vitro packaging of the recombinant bacteriophage vectors prepared in (ii), infection of the chosen prokaryotic cells and recovery of clonal phage particles as plaques on a bacterial lawn; (iv) screening of the recombinant cloned phage particles obtained in (iii) for the nitrate reductase gene, by ho ology with other known nitrate reductase genes from various species, or by functional activity; (v) recovery of the nitrate reductase gene by suhcloning suitable 0 restriction fragments of the recombinant phage into vectors known to be capable of transformation and replication in the chosen prokaryote, preferably E. coli; (vi) insertion of the desired industrially important gene, or genes, particularly biosynthetic or regulatory genes involved in cephalosporin or penicillin biosynthesis, preferably by the fusion of DNA fragments with vectors obatined in (v) in such a way that both genes are expressed, that is the fusion does not disrupt the functional activity of the nitrate reductase gene or those functions necessary for o replication and selection in the prokaryotic host; (vii) as an additional, but not essential step, other component DNA fragments may also be fused to the vectors described in (v) and (vi), for examples, DNA fragments hβving autonomously replicating ability in 25 yeasts or other filamentous fungi; (viii) transformation of a nitrate reductase deficient host strain of P. chrysogenum or A. chrysogenum using the vector obtained in the prokaryotic transformants prepared as in steps (iv-vii) above and . Q containing the industrially important gene and the nitrate reductase gene identified by the means in (iii) and (iv), such transformation SUBSTITUTE SHEET preferably brought about by preparation of fungal protoplasts by enzymatic digestion of cell wall components in high osmotic strength medium and introduction of the vectors to the protoplasts by treatment with polyethylene glycol; (ix) selection on a medium containing nitrate as the sole nitrogen source for fungal transformants expressing the newly introduced nitrate reductase gene as selectable marker, for the preferred transformation system (viii), such medium to have high osmotic strength to allow protoplast regeneration. It will be understood that steps (ii) and (iii) may be replaced by fusion of restriction fragments directly to vectors as described in (v) and screening for niaD as in (iv). It will also be understood that the industrially important gene or genes may reside on a separate vector moiety or restriction fragment and that step (viii) can be performed as a co-transformation of the distinct vector DNA moieties, selecting for the presence of the niaD gene and screening by hybridisation or functional activity for uptake of the industrially important gene. Transformed cells prepared according to the process of the invention may then be used in the production of penicillins or cephalosporins by fermentation. Thus in another aspect of the invention we provide for a method of producing a penicillin or a cephalosporin which comprises culturing a transformed strain of P. chrysogenum or A. chrysogenum prepared by the method of the invention as described above and isolating the desired penicillin or cephalosporin from the culture medium. In a further aspect of the present invention, we provide vector DNA which includes a marker gene coding for nitrate reductase, said gene being operatively linked to a control sequence for expression of said gene, preferably, the gene coding for nitrate reductase and optionally the control sequence are both derived from cells of the same SUBSTITUTE SHEET species as the intended transformation host, P. chrysogenum or A. chrysogenum. A particularly preferred vector DNA contains, in addition to a marker gene coding for nitrate reductase, at least one gene, as described above, which will result in an improved strain following transformation of P. chrysogenum or A. chrysogenum. In another aspect of the present invention, we provide transformed cells of P. chrysogenum and A. chrysogenum containing vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the transformed host cells. In the following non-limiting Examples which illustrate the present invention, the following abbreviations are used :- EPTA - ethylenediaminetetraacetic acid; EGTA - ethyleneglycol-bis- (β-aminoethyl ether)N,N'-tetraacetic acid; SPS - sodium dodecyl sulphate; Tris-HCl - tris(hydroxymethyl) aminomethane hydrochloride; PTT - PL-dithiothreitol; ATP - adenosine triphosphate; SSC - saline sodium citrate; PEG - polyethylene glycol; SSPE - saline sodium phosphate/EPTA; kb - kilobase pairs of PNA. Sυ BST f TUTE SHEET Example 1 : Heteroloqous Transformation System. Based Upon the Use of Nitrate Reductase Genes from Related Fungi in Penicillium chrysogenum Step 1: Isolation of Aspergillus nidulans niaD Gene-Specific Probe Plasmid pNIIA was isolated from an A. nidulans gene library constructed in the argB gene-based cloning vector pll_J16 (Johnstone et al, EMBO J. 4, (1985), 1307-1311 by its ability to complement a niiA4 (nitrite reductase gene), argB2 double mutant strain. Further complementation experiments with a number of genetically identified deletions extending into the niaD gene (nitrate reductase gene) have shown that pNIIA contains the entire crnA gene (nitrate permease) and part of niaD. The position of the niiA-complementing DNA fragment of pNIIA relative to a restriction map of the niiA and niaD gene region is illustrated in Figure 1. This map is illustrative only, in that a limited number of restriction sites are shown and in some instances, not all sites of a particular restriction enzyme have been mapped. DNA of pNIIA was digested with EcoRl and reiigated to construct the plasmid pSTAl . This treatment provided a means of deleting all the DNA to one side of the EcoRl site (illustrated in Figure 1) and thus removing all crnA and niiA gene encoding sequences. A 2.4 kb Xbal fragment from within the pSTAl DNA contains part of the niaD gene and thus provides a means of screening further isolated clones for the presence of an intact niaD gene. The plasmid pSTAl was deposited under the terms of the Budapest Treaty on the International Recognition of the Deposit of Micro-organisms for the Purposes of Patent Procedure, at the National Collection of Industrial and Marine SUBSTITUTE SHEET Bacteria, 135 Abbey Road, Aberdeen, AB9 8DG on 23rd January 1989 under the Accession number NCIB 40102. A 10 ug aliquot of pSTAl DNA was brought to 1 x Xbal buffer conditions (10 mM Tris- HCI, pH 7.5, 7 mM MgC^, 100 mM NaCI, 7 mM 2-mercaptoethanol) and digested with 100 units Xbal enzyme (Amersham, International Pic, White Lion Road, Amersham, Bucks, HP7 9LL). The restriction products were resolved on a 1% low melting temperature agarose gel (Sigma Chemical Co, Fancy Rd, Poole, Dorset, BH17 7NH) by electrophoresis under standard conditions. The DNA band containing the 2.4 kb Xbal fragment was excised, remelted at 42°C and the DNA recovered by phenol extraction and ethanol precipitation. This material was used as a niaD-specific probe in order to isolate an intact, functional niaD gene. Step 2: Aspergillus nidulans DNA Library Construction An A. nidulans strain proficient in nitrate utilization was grown at 28°C in Aspergillus Complete Medium, ACM (Clutterbuck, in Handbook of Genetics (King, Ed.) pp 447-510 Plenum Press, 1974). Suitable strains are widely available from various fungal culture collections, eg: American Type Culture Collection (ATCC) 12301 Parklawn Drive, Rockville, MD 20852, USA; Commonwealth Mycological Institute, Ferry Lane, Kew, Surrey, TW9 3AF; Fungal Genetics Stock Centre, California State University, Humboldt, Arcata, CA 95521 , USA. Mycelium was harvested after overnight growth by filtration, frozen in liquid nitrogen and lyophilised overnight. This material was used to isolate high molecular weight DNA using a modification of the method of Raeder and Broda (Lett. Applied Microbiol. 1 (1985), 17-20). The lyophilised mycelium (2.5 g) was ground with 0.1 volumes of sand and rehydrated in 5 ml of an extraction buffer consisting of 25 mM EDTA, 0.5% SDS and 250 mM NaCI in 200 mM Tris-HCI, pH 8.5. A 3.5 ml aliquot of phenol (equilibrated with extraction buffer) was added and mixed, followed by 1.5 ml chloroform/isoamyl alcohol (24:1) then the solution was vortexed. The lysate was centrifuged at 12000 g for one hour at room temperature, then nucleic acids were precipitated from the aqueous phase with 0.6 vol propan-2-ol. The loose pellet obtained on standing was washed in 1 ml 70% ethanol and raised in 1 ml TE buffer (10 M Tris-HCI pH 8.0, 1 mM EDTA). RNA was precipitated by the addition of 7.5 M ammonium acetate to 2.5 M and incubation at 4°C for 15 minutes. After a brief centrifugation, as above, DNA was precipitated from the aqueous phase with 2 vol ethanol. The pellet was washed in 70% ethanol, dried and raised in 1 ml TE buffer in about 1 mg yield. The DNA, obtained as above was partially restricted with the enzyme Sau3AI (Amersham International Pic). A 200 ug aliquot was adjusted to 1 x Sau3AI buffer conditions (10 mM Tris-HCI, pH 7.5, 7 mM MgC^, 20 mM NaCI) in a 500 ul volume, then digested with 1.5 units enzyme for 1 hour at 37°C. The reaction was terminated by the addition of EDTA to 10 mM and then the reaction products size fractionated through a preformed 38 ml sucrose gradient, (10-40% sucrose in IM NaCI, 5 mM EDTA, 20 mM Tris-HCI pH 8.0) centrifuged for 20 h at 90000 g and 21 °C in an SW28 rotor (Beckman Instruments (UK) Ltd, Progress Rd, High Wycombe. Bucks, HP12 4JL). The gradient was fractionated into 0.5 ml aliquots and DNA of size range 15 kb-25 kb (as determined by agarose gel electrophoresis) was pooled, adjusted to 0.3 M in sodium acetate and precipitated in SUBSTITUTE S ethanol by addition of 2 volumes ice-cold ethanol and incubation on ice for 30 minutes. The DNA pellet recovered by centrifugation was raised in 25 ul TE buffer. The lambda cloning vector ^EMBL3 (Frischauf et al, J. Mol. Biol. 170: (1983) 827-842) was obtained as BamHI digested arms from Stratagene Inc (11099 North Torrey Pines Rd, La Jolla, CA 92037, USA). The Sau3AI fragments of A. nidulans DNA (1 ug) and ΕMBL3 arms (2 ug) were mixed in 20 ul ligation buffer (20 mM Tris-HCI, pH 7.6, 10 mM MgCI 2 , 10 mM DTT, 0.6 mM ATP) and incubated at 14°C for 18 hours with 5 units T4 DNA ligase (Amersham). The ligation products were packaged in vitro into phage particles using the commercially available Gigapack Kit (Stratagene Inc). The packaged phage were propagated in the E. coli strain Q358, creating a recombinant phage library of 1.5 x 10^ plaque forming units (pfu). Step 3: Isolation of a Functional Aspergillus nidulans niaD Gene Clone Approximately 3 x 10 4 pfu of the A. nidulans recombinant phage library were mixed with 1 x 10 8 E. coli Q358 cells in 0.5 ml 10 mM MgSOφ After 15 minutes incubation at 37°C the mixture was added to 25 ml molten (42°C) soft agar (LB + 10 mM MgSC. } + 0.6% agar) and used to overlayer a 20 x 20 cm petri plate containing LB medium + 10 mM MgSO^ (LB (Luria-Bertani) medium contains 1% Bacto-tryptone, 0.5% yeast extract, 0.5% NaCI at pH 7.0. Standard techniques for handling E. coli are described by Maniatis et al, Gene Cloning. A Laboratory Manual. Cold Spring Harbor Lab, New York, 1982). Following overnight incubation, duplicate filter impressions of the plate were taken using Hybond-N membranes (Amersham) by standard techniques. The filters were each incubated in 25 ml of pre-hybridisation buffer (6 x SSC, 5 x Denhardt solution, 0.5% sodium dodecyi sulphate (SDS) and 500 ug denatured salmon sperm DNA at 65°C for 6 hours. SSC is 0.15 M NaCI, 0.015 M sodium citrate; Denhardt solution is 0.02% of each of polyvinyipyrrolidone, bovine serum albumin, ficoll (Sigma Chemical Co). The 2.4 kb Xbal fragment of pSTAl (a niaD-specific DNA fragment), prepared as in step 1 , was labelled with 32 P by the method of nick-translation using a commercialiy available kit (Amersham). The radioactively-iabelled fragment was recovered free from unincorporated label by elution from a Sephadex G-50 Nick Column (Pharmacia LKB Biotechnology, Midsummer Boulevard, Milton Keynes, Bucks MK9 3HP) and added to fresh 25 ml aliquots of hybridisation buffer (prepared as for prehybridisation buffer). Hybridisation was at 65°C overnight. The filters were then washed free of excess probe using standard conditions to a final wash of 0.1 x SSC, 0.1% SDS at 65°C and the dried filters exposed to X-ray film (Hyperfilm B-max, Amersham) at -20°C for 4 days. Putative positive plaques were picked and reprobed at a lower plating density (approximately 100 plaques per 9 cm diameter plate). One positive clone (\AN8a) isolated in this way was retained for further use. This clone encodes the entire niaD gene of A. nidulans as illustrated in Figure 1, and is a source of exogenous DNA for our transformation protocol. SUBSTITUTE SHEET Step 4: Isolation of a Functional Aspergillus niger niaD Gene Clone A nitrate utilizing A. niger strain was grown in complete medium essentially as described in Step 2. Suitable strains are widely available through ATCC, CM I, FGSC or other culture collections. The mycelium was harvested and DNA isolated by the method described in Step 2. Southern blotting of A. niger genomic DNA using the 2.4 kb Xbal fragment of pSTAl as a niaP-specific probe revealed that the A. niger nitrate reductase (niaD) gene resides on DNA fragments of about 2.8 and 2.0 kb when digested with EcoRl. Experimental conditions for hybridisation and production of 32 P-labelled probe were essentially as described in Step 3. Background, non-hybridised radioactivity was removed by washing to a final salt concentration of 2 x SSC at 56°C. A. niger genomic DNA (50 ug) was brought to 1 x Sau3AI buffer conditions and digested with 2 units Sau3AI at 37°C for 30 minutes in a 200 ul volume. Fragment in the range 6-12 kb were isolated from a 1% agarose gel by centrifugation through nitrocellulose (Zhu et al. Biotechnol. 3 (1985), 1014-1016). A 2 ug DNA aliquot of the widely available plasmid vector pUC8 (vϊeira and Messing, Gene _9 (1982), 259-268) was adjusted to 1 x BamHI buffer conditions (10 mM Tris-HCI pH 8.0, 7 mM MgC^, 100 mM NaCI, 2 mM 2-mercaptoethanol) and digested with 10 units BamHI at 37°C for 2 hours in a 10 ul volume. DNA was precipitated by addition of ammonium acetate to 2M and 2 volumes of cold ethanol. The DNA pellet recovered by centrifugation was raised in 20 ul of 50 mM Tris-HCI pH 8.0, 0.1 mM EDTA and incubated with 0.5 units of Alkaline Phosohatase (Boehringer Mannheim GmbH, PO Box 310 120. SUBSTITUTE SHEET D-6800, Mannheim 31 FRG) at 37°C for 1 hour. The phosphatase was inactivated by addition of EGTA to 10 mM and heating to 65°C for 45 minutes. The DNA was precipitated by addition of sodium acetate to 0.3 M and 2 volumes of cold ethanol. Aliquots containing approximately 250 ng of the A. niger Sau3AI fragments and 100 ng of the dephosphorylated BamHI cut pUC8 vector were mixed and ligated essentially as described in Step 2. The ligation products were used to transform the widely available E. coli strain DH5 to produce an A. niger DNA library of around 2 x 10 4 clones enriched for fragments expected to carry the nitrate reductase structural gene. The library was divided into 9 pools each containing approximately 1500-3000 individual clones. The pooled isolates were grown in LB medium supplemented with 100 ug/ml ampicillin and DNA isolated by a modification of the alkaline SDS method of Birnboim and Doly (Maniatis et al, loc cit). The isolated DNA was digested with EcoRl and BamHI. resolved by electrophoresis, blotted and probed with 32 P-labeiled niaD- specific 2.4 kb Xbal fragment of pSTAl, isolated as described in Step 1. One of the pools contained fragments which showed strong homology to this probe. This pool was used to isolate niaD-specific clones by standard colony hybridisation as described by Maniatis et al (loc. cit.), again using the pSTAl DNA fragment as probe. Two clones were isolated by this means. One of them was subsequently used in other tests and is designated pSTAlO. A restriction map of pSTA10 (Figure 2) illustrates the approximate location of the niaD gene relative to the A. niger DNA fragment present in pSTA10. This map is intended to be illustrative only, in that a limited number of restriction sites are shown and in some instances not all sites of a particular restriction enzyme have been mapped. SUBSTITUTE SHEET Step 5: Isolation of a Functional Aspergillus oryzae niaD Gene Clone A genomic DNA library of the A. oryzae strain ATCC 91002 was prepared in the >^EMBL3 vector as described in step 2. The initial phage library contained about 1 x 10 5 pfu. About 4 x 10 4 pfu were propagated in the widely available E. coli strain NM259 and screened for the presence of niaD gene sequences by hybridisation as described in step 3. The 2.4 kb Xbal fragment of pSTAl containing part of the A. nidulans niaD gene, isolated as described in step 1 , was used as the hybridisation probe. Two clones were identified as containing niaD gene sequences by this means. One of these designated XSTA62 was used for further subcloning work. Approximately 5 ug of DNA isolated from ,\STA62 was adjusted to 1 x Sal] buffer conditions (10 mM Tris-HCI, pH 8.0, 150 mM NaCI, 10 mM MgCI , 1 mM 2-mercaptoethano!) and digested with 50 units Sail at 37°C for 2 hours in a 50 ul reaction volume. The digest fragments were resolved on an 0.8% agarose gel and an 8.2 kb fragment was isolated as described in step 4. This fragment was known to carry the A. oryzae niaD gene by virtue of homology with the A. nidulans niaD gene probe. A 1 ug aliquot of the widely available plasmid vector pUClδ (Yanisch-Perron et al. Gene 33 (1985), 103-119) was similarly digested with 10 units Sail. Approximately 100 ng quantities of the isolated 8.2 kb A. oryzae Sail fragment and the Sail-digested pUClδ were ligated using 1 unit T4 DNA ligase as described in step 2. The ligation products were used to transform the widely available E. coli strain DH5. Ampicillin resistant colonies were screened for the presence of plasmids containing the required insert DNA using the modified alkaline SDS method of Birnboim and Doly as described by SUBSTITUTE SHEET Maniatis et al (loc. cit.). A plasmid isolate carrying the 8.2 kb Sail fragment from ^STA62 was identified and designated pSTA1 . A restriction map of the A. oryzae DNA present in pSTAl4 is shown in Figure 3. The map is intended to be illustrative only, in that a limited number of restriction enzyme sites are shown and in some instances not all sites of a particular restriction enzyme have been mapped. Step 6: Isolation of Penicillium chrysogenum niaD ' Mutants The P. chrysogenum strain Q176 (ATCC 10002) was grown on Aspergillus Complete Medium (Clutterbuck, loc. cjt) supplemented with 10 mM NH 4 CI and solidified with 1.5% agar. Conidia were harvested by suspension in 0.01 % Tween 80. Approximately 10 8 conidia were spread plated on to chlorate selection medium based upon Aspergillus Minimal Medium, AMM (Clutterbuck, loc. cit) supplemented with 6 mM L-arginine and 94 mM NaClθ3 as described (Birkett and Rowlands, J. Gen. Microbiol. 123 (1981): 281-285). The basis of this chlorate selection for mutants unable to utilise nitrate as sole nitrogen source is well documented and is reviewed by Cove, Biol. Revs. 54 (1979), 291-327. Colonies which grew strongly were picked and purified as examples of spontaneously occurring chlorate-resistant mutants. Isolates were tested for reversion to nitrate utilisation by plating conidia on AMM containing 20 M sodium nitrate and scoring growth. Those with a reversion rate of less than 10" 8 nitrate proficient isolates/ input conidia were further tested for growth on a variety of nitrogen sources (Birkett and Rowlands, loc. cjt). Those which grew on nitrite (1.5 mM) or adenine (0.6 mM adenine hydrochloride) but failed to grow on nitrate were deemed to be nitrate reductase gene mutants and termed niaD' (by analogy to the A. nidulans criteria). SUBSTITUTE SHEET These isolates were further tested for nitrate reductase enzyme activity using the biochemical method of Cove (Biochim. Biophys. Acta, 1__3 (1966), 51-56). Mycelium was grown in AMM broth supplemented with 20 mM NaNOs for 26 hours at 26°C, 290 rpm for these assays. The isolates of the niaD type showed minimal nitrate reductase activities in these assays, while Q176 contained normal levels of the enzyme. A strain designated S1900 is an example of such a spontaneously occurring niaD ' mutant and was deposited at the Commonwealth Mycology Institute Culture Collection, under the terms of the Budapest Treaty on 23rd January 1989 under the Accession number CMICC 330177. Step 7: Preparation of Penicillium chrysogenum Protoplasts Approximately 10 8 conidia of the mutant S1900 were grown in 100 ml ACM for 42 hours at 26°C with shaking (220 rpm). The mycelium was recovered by filtration on to Whatman No. 1 paper, then resuspended in 0.7 M KCI, 10 mM phosphate buffer pH 5.8 containing Novozym 234 (Novo Industri, A/S DK2880 Bagsvaerd, Denmark) at 10 mg/ml. This buffer is added at a rate of 10 ml/gram wet weight cells. The cell suspension is incubated at 26°C with gentle shaking for 2 hours, then protoplasts separated from the bulk of mycelial debris by filtration through a sintered funnel (porosity 2). Protoplasts were recovered by centrifugation at 4000 rpm for 10 minutes in a bench top centrifuge. The protoplast pellet was washed twice in 5 ml 0.7 M KCI, 50 mM CaCl2 buffer, recovered and finally resuspended to a density of about 5 x 10 8 protoplasts/ml in KCI/CaCI 2 buffer. SUBSTITUTE SHEET Step 8: Transformation of S1900 Protoplasts A 500 ul aliquot of S1900 protoplasts prepared as in step 7 was mixed in a 1.5 ml polypropylene tube with 10-30 ug DNA (in TE buffer) of λANδa, pSTA10 or pSTA14. An equal volume of 50% polyethylene giycol (PEG-4000, Sigma Chemical Co) in 0.7 M KCI, 50 mM CaCl2, 10 mM Tris-HCI, pH 7.5, was added and the mixture held on ice for 30 minutes. The mixture was then diluted to 1.5 ml with KCI/CaCl2 buffer and aliquots spread on to AMM agar supplemented with 20 mM Na O β as sole nitrogen source and 0.7 M KCI as osmotic stabiliser. The plates were incubated at 26°C for 7-10 days to allow nitrate-utilising transformants to grow out of the background of nitrate non-utilising material. The frequency of transformation was approximately 10 transformants per ug exogenous DNA when using the A nidulans niaD gene clone λANδa or the A. niger gene clone STA10, but only about 2 transformaπts/ug DNA of the A. oryzae gene clone pSTAl . The S1900 transformant isolates generally showed improved sporulatioπ ability and distinctly altered colony morphology. The transformation of S1900 was also confirmed by Southern blotting using standard methodology as described by Maniatis et al (loc. cjt.) and hybridisation of the genomic DNA of transformant isolates with 32 P-labelied fragments of χAN8a, pSTAlO or pSTA14 DNA. The labelling of the probe fragments was essentially as described in step 3. Hybridisation conditions were; 5 x SSC, 5 x Denhardts solution, 50 mM phosphate buffer pH 6.5, 20 ug/ml sonicated herring sperm DNA. Blots were washed at 65°C by several stages from 5 x SSC to a final salt concentration of 0.1 x SSC in the presence of 0.1% SDS. Analysis of transformants by these techniques revealed that the exogenous DNA of either XANδa, pSTAlO or pSTA14 had integrated into the P. chrvsooenum S1900 recipient genome. Restriction analysis showed that the integration site was different in each of the transformants and that the number of integration events could vary in each transformant. Example 2: Homologous Transformation System for Acremonium chrysogenum Based upon the Native Nitrate Reductase Gene Step 1 : Isolation of the Acremonium chrysogenum Nitrate Reductase Gene A. chrysogenum strain M8650 (ATCC 14553) was grown in the defined liquid medium of Demaiπ, as described by Queener et al (Microbiology, 1985, Leive L Ed. pp 468-472. American Society for Microbiology, Washington DC, 1985). The mycelium was harvested and high molecular weight DNA isolated as described in Step 2 of Example 1. An M8650 genomic library was constructed by ligating partial Sau3A1 digestion fragments (15-20 kb) into the BamHI cloning site of XEMBL3 using standard techniques (Maniatis et aj joe. cit.), as described in Step 2 of Example 1. The in vitro packaged recombinant phage particles (about 1.3 x 10^ pfu) were propagated in the widely available E. coli strain NM259 to give an amplified library of around 1 x 10 10 pfu/ml. For screening, 12 plates (9 cm diam) each containing about 2 x 10 4 pfu were prepared using standard methodology (Maniatis et al, joe cjt). Duplicate filter impressions of each plate were taken on nitrocellulose membranes. Filters were prehybridised for about 4 hours at 56°C in the following prehybridisation buffer at about 4 ml buffer per filter; 5 x SSPE (0.9 M NaCI, 50 mM Na H 2 P0 4 . 5 mM EDTA), 6% PEG6000, 0.5% dried milk powder, 1% SDS, 0.125% Na 4 P0 7 , 250 ug/ml sonicated herring sperm DNA. The library was screened with the 2.4 kb Xbal fragment from within the A. nidulans nitrate reductase gene. This fragment was isolated as described in Step 1 of Example 1. Isolated fragment (25 ng) was radioactrvely labelled with 3 P using Klenow polymerase with random priming from mixed hexamer oligoπucleotides (Multiprime Kit, Amersham) following the manufacturers guidelines. The library filters were hybridised overnight at 56°C in fresh prehybridisation buffer containing the radioactive probe. Background radioactivity from non-hybridised probe was removed by washing twice at 56°C for 20 minutes in a buffer containing 5 x SSC, 0.1% SDS, 0.1 % SSPE (approximately 10 ml/ filter) then twice at 56°C for 20 minutes in 3 x SSC, 0.1% SDS, 0.1% SSPE. The washed filters were exposed to X-ray photographic film for 3 days at -70°C with intensifying screens. A number of putative positive plaques were identified. They were plaque purified and re-tested during two further rounds of hybridisation screening. Two strongly positive clones were confirmed by this procedure. One of these, termed Λ STA6 . w as used in subsequent work. An 8.8 kb EcoRl fragment present within ,\STA6 is of the same size as an EcoRl fragment of M8650 genomic DNA identified by Southern blotting as being homologous to the 2.4 kb Xbal fragment containing part of the A. nidulans niaD gene. A phage stock of ΛSTA6 was prepared and DNA isolated using standard methodology (Maniatis et al. loc cit). Approximately 5 ug of XSTA6 DNA was digested with 25 units EcoRl in a 50 ul reaction containing 100 mM Tris-HCI pH 7.5, 7 mM MgCI 2 , 50 mM NaCI, 7 mM 2-mercaptoethanol at 37°C for 2 hours. The digestion products were resolved by electrophoresis on a 0.8% agarose slab gel. The 8.8 kb fragment was recovered by the sodium iodide-glass method (Vogelstein and Gillespie, Proc. Natl. Acad. Sci. USA 76 SUBSTITUTE SHEET (1979), 615-619) using a commercially available kit (Geneclean; Bio 101 Inc, PO Box 2284, La Jolla, CA 92038, USA). A 1 ug aliquot of plasmid pUC18 was similarly digested with 10 units EcoRl. Approximately 100 ng quantities of the 8.8 kb EcoRl fragment of XSTA6 and EcoRl digested pUClδ were ligated using 2.5 units T4 DNA Ligase as described in Step 2 of Example 1. The ligation products were used to transform E. coli strain DH5. Ampicillin resistant colonies were screened for the presence of plasmid DNA using the alkaline SDS lysis method as described by Maniatis et al (loc cjt). A plasmid isolate carrying the 8.8 kb EcoRl fragment from XSTA6 was identified and termed pSTA700. A restriction map of the A. chrysogenum DNA portion of pSTA700 is shown in Figure 3. This map is intended to be illustrative only, in that a limited number of restriction enzymes have been used and in some instances not all sites of a particular restriction enzyme are shown. The map is presented as an aid to discussion. The plasmid pSTA700 was deposited in the National Collection of Industrial and Marine Bacteria under the terms of the Budapest Treaty on 23rd January 1989 under the Accession number NCIB 40103. Confirmation of the presence of the niaD gene within pSTA700 was obtained by Southern blotting performed as described above. The pSTA700 plasmid was used to probe A chrysogenum genomic DNA digested with EcoRl. Bglll or BamHI. This probe gave identical banding patterns in these digests to those obtained when using the 2.4 kb Xbal fragment of pSTAl as probe, ie: an EcoRl fragment of 8.8 kb, BamHI fragments of 8.0 and 3.8 kb and Bglll fragments of 6.4, 2.5 and 1.3 kb. This confirms the presence of A. chrysogenum DNA associated with the niaD gene within the pSTA700 plasmid. and also shows that no gross rearrangements have occurred during the cloning process SUBSTITUTE SHEET The niaD gene was further localised within pSTA700 by Southern blotting. The probe used in this case was a 124 bp Pstl-Accl fragment of the A. nidulans niaD gene. This fragment contains a region of the niaD gene which is highly conserved among fungal and plant nitrate reductase genes. The location of this fragment is indicated in Figure 1. A 5 ug aliquot of pSTAl DNA was digested with 10 units Pstl and 10 units Accl in a 50 ul reaction volume containing 10 mM Tris-HCI pH 7.5, 7 mM MgCI 2 , 60 mM NaCI, 7 mM 2-mercaptoethanol at 37°C for 2 hours. The digestion products were resolved by electrophoresis on a 2% agarose gel and the 124 bp fragment recovered using Geneclean. The fragment was radioactively labelled with 2 P using the random priming method. Prehybridisation, hybridisation and filter washing were as described above. The Southern hybridisation experiment revealed a 1.3 kb Bglll fragment of pSTA700 with homology to the niaD-specific probe fragment. Step 2: Isolation and Characterisation of Nitrate Reductase Gene Mutants of Acremonium chrysogenum A. chrysogenum M8650 mycelium was grown in Demaiπs medium for 5-8 days at 28°C with shaking (220 rpm). Conidiospores were obtained by vacuum filtration through a sterile Whatman no 1 filter paper in a Buchner funnel. The filtrate was collected in a sterile flask and conidia recovered by centrifugation. A 100 ml culture of M8650 yielded around 2 x 10 10 conidia by this method. Conidia are stored in aliquots over liquid nitrogen using 10% methanol as cryopreservative . Approximately 10 8 non-mutagenised conidia, were spread plated at around 10 7 conidia/plate onto Aspergillus minimal media. AMM (Clutterbuck loc cit, as described SUBSTITUTE SHEET in Step 6 of Example 1) supplemented with 10 mM glutamate and 470 mM sodium chlorate. After 12-14 days incubation at 28°C, spontaneous chlorate resistant mutants were isolated. Initial characterisation of the mutants was carried out using simple nitrogen growth tests described by Birkett and Rowlands Qoc cit). The nirA. crnA and areA type mutants could be distinguished from niaD and cnx mutants (A. nidulans gene designations are used as standard). These growth tests could not readily distinguish niaD and cnx-type mutants as A. chrysogenum failed to grow on hypoxanthine (unlike A, nidulans) or adenine (unlike P. chrysogenum). A simple phenotypic assay to distinguish niaD and cnx type mutants was developed using alternative purines as sole nitrogen source. When using quinic acid (1 %) as carbon source and inosine (2 mM) as nitrogen source in a medium based on AMM, niaD mutants were found to grow, while cnx mutants could not. The phenotypes assigned to niaD or cnx mutants were further confirmed by enzyme assays. A cnx mutant should lack purine hydroxylase I enzyme activity since this enzyme requires a molybdenum-containing cofactor which is also a common requirement for nitrate reductase activity. Purine hydroxylase I catabolises hypoxanthine to xanthine to uric acid (Lewis et al. Euro. J. Biochem. 91 (1978), 311-316). The assay for purine hydroxylase I was performed essentially as described by Mendel and Muller (Biochem. Physiol. Plantzen. 170 (1976) 538-541). In brief, A. chrysogenum M8650 and putative niaD or cnx mutants were grown in liquid Aspergillus Complete Medium (Clutterbuck, 1974 joe. cit.) for 24 hours at 28°C, 220 rpm harvested by centrifugation, resuspended in liquid AMM supplemented with 500 mM uric acid and incubated for a further 3.5 hours at 28°C. 290 rpm. The mycelium was harvested, ground to a fine powder in liquid nitrogen and extracted into 0.1 M potassium phosphate buffer pH 7.5 containing 1 mM EDTA. 10 mM 2-mercaptoethanol. 1 % Triton X-100 at 2 ml buffer/g wet weignt mvceiium. After centrifugation at 20000 rpm in a SW27 rotor (6 x 14 ml tubes, Beckman Instruments) for 20 minutes at 4°C, the extracts (100 ul aliquots) were loaded on to non-denaturing 7% polyacrylamide tube gels prepared by standard techniques (for example see Hames and Rickwood, Gel Electrophoresis of Proteins. A Practical Approach. IRL Press, London, 1981). After electrophoresis at 5 mA until the bromophenol blue tracking dye reached the bottom of the gel, the gel was stained for purine hydroxylase I activity in the dark in 0.1 M sodium pyrophosphate buffer, pH 8.0, containing 2 mM hypoxanthine, 1 mM nitrotetrazolium blue (Sigma Chemical Co), 0.1 mM phenazine methosulphate (Sigma). Some of the isolates tested were found to lack purine hydroxylase activity by this test and were assigned as cnx mutants. To further characterise niaD mutants, isolates were also tested for the nitrate reductase enzyme property of NADPH-linked cytochrome C reductase activity using the methods described by Cove and Coddington (Biochim. Biophys. Acta, 110 (1965), 312-318) and Wray and Filπer (J. Biochem. 1__9 (1970), 715-725). Isolates which retained purine hydroxylase I activity but with greatly reduced levels of NADPH-linked cytochrome C reductase activity were assigned as niaD mutants. The isolates with reduced purine hydroxylase I activity showed wild type levels of NADPH-linked cytochrome C reductase activity consistent with them being cnx mutations. The niaD mutants were screened for rates of reversion to nitrate utilization as described in Step 6 of Example 1. Stable mutants were identified as having reversion frequencies of less than 10 "8 revertants/conidiospore. One of these isolates, designated as A. chrysogenum strain M1160 was used as a suitable recipient for transformation by vectors containing intact niaD genes. This strain was deposited in the Commonwealth Mycological Institute Culture Collection under the terms of the Budapest Treaty on 23rd January 1989 under the Accession number CMICC 330176 SUBSTITUTE SHEET Step 3: Preparation of Protoplasts from Acremonium chrysogenum The strain M1160 was grown from a conidial inoculum (about 10 8 conidia) in 100 ml Demains medium (Queener et al. loc cit) for around 40 hours at 28°C with shaking at 290 rpm. Mycelium was harvested in sterile muslim, washed with distilled water and resuspended in 0.1 M citrate-phosphate buffer, pH 7.1 , 10 mM dithiothreitol at 50 ml buffer per gram wet weight mycelium. This was gently shaken for 30 minutes at 28°C, then the mycelium was recovered and resuspended in 0.1 M citrate-phosphate buffer, pH 5.8 containing, 0.7 M KCI, 5 mg/ml Novozyme 234 (Novo industri) at 50 ml/g mycelium. The material was incubated for a further 60 minutes at 28°C with gentle shaking. The resultant protoplasts were harvested through a sintered glass funnel (porosity 1) under slight vacuum and collected by pelleting at 3000 rpm for 10 minutes. The pellet was washed 3 times in 0.7 M KCI, then resuspended at a concentration of around 1 x 10^ protoplasts/ml. Step 4: Transformation of M1160 Protoplasts Aliquots of 100 ul protoplast suspension were transferred to 1.5 ml polypropylene tubes and CaCI 2 was added to 50 mM final concentration. A 10 ug quantity of DNA of either XSTA6 or pSTA700 in a volume of less than 20 ul TE buffer, and 10 ul PEG solution (50% PEG 4000 (Sigma Chemical Co), 50 mM CaCI 2 . 10 mM Tris-HCI, pH 7.5) were added and mixed by hand. Control samples were also set up with no exogenous DNA present. The mixtures were incubated at room temperature for 20 minutes before a further 900 ul PEG solution was added. After 20 minutes incubation tne protoplast SUBSTITUTE SHEET mixtures were spread in 0.1 ml aliquots on minimal medium plates (AMM, supplemented with 10 mM NaN03 as nitrogen source and 11% sucrose as osmotic stabiliser). The plates were incubated at 28°C for up to 21 days. Transformant colonies usually grew strongly out of a faint background growth within about 10 days. The basic procedure described above routinely yields about 2-4 transformants/ug DNA, pSTA700 DNA giving slightly greater transformation frequencies than XSTA6. Modifications of the transformation protocol give improved frequencies, namely:- (i) Cold Shock: The first 20 minute incubation of protoplasts, DNA and PEG solution is carried out on ice. This results in transformation efficiencies of around 6- 7 transformants/ug DNA. (ii) Heat Shock: The mixtures are transferred to a water batch at 35°C for 2 minutes after the first 20 minutes incubation, before addition of the 900 ul of PEG solution. This results in transformation frequencies of around 9-10 transformants/ug DNA. As in Step 8 of Example 1, transformant colonies were purified by subculture on minimal medium supplemented with nitrate. Uptake of exogenous DNA was proved by Southern blotting of the transformant genomic DNA. using the input vector DNA, either XEMBL3 or pUCl8, as hybridisation probe. The hybridisation conditions and probe preparation were as described in steps 3 and 8 of Example 1. SUBST/TUTE SHEET As referenced in the accompanying text, the following drawings are included: Figure 1 : Restriction Map of the Aspergillus nidulans niaD Gene Locus The niaD structural gene is indicated by the position of the hatched area with the direction of transcription shown by the arrow. The bars represent the portions of this region present in the recombinant constructs described in the text. The Xbal. Pstl and Accl sites highlighted (*) delimit fragments used as hybridisation probes (see text). Figure 2: Restriction Map of the Aspergillus niger niaD Gene Locus The map represents the fragment of A. niger DNA carried by the plasmid pSTAIO. The niaD structural gene is indicated by the position of the hatched area. The direction of transcription was deduced by hybridisation to 5' and 3' end specific probes from the A. nidulans niaD gene. Figure 3: Restriction Map of the Aspergillus oryzae niaD Gene Locus The map represents the 8.2 kb SaH fragment of A. oryzae DNA carried by the plasmid pSTA14. The niaD structural gene is positioned within the 5.5 kb Hindlll fragment as indicated (*). Figure 4: Restriction Map of the Acremonium chrysogenum niaD Gene Locus The map represents the 8.8 kb EcoRl fragment of A. chrysogenum DNA carried by the plasmid pSTA700. The niaD structural gene location is indicated by the hatched area. The direction of transcription (arrowed) was deduced from DNA sequence analysis and comparison to the A. nidulans niaD gene.

Claims: CLAIMS ; 1. A process for obtaining cells of Penicillium chrysogenum or Acremonium chrysogenum capable of expressing nitrate reductase from cells of the same species which are initially deficient in expression of the nitrate reductase gene (niaD- cells) , which comprises introducing into said niaD- cells vector DNA including a marker gene coding for nitrate reductase operatively linked to a control sequence for expression of said gene within the selected host cells, followed by selection of cells thus transformed by their ability to grow on a suitable medium containing nitrate as the only source of nitrogen. 2. A process as claimed in claim 1 characterised in that the marker gene coding for nitrate reductase is isolated from the same species as the chosen transformation hosts. 3. A process as claimed in either of claims 1 and 2 characterised in that the said marker gene coding for nitrate reductase is isolated from a strain selected from Aspergillus niger, Aspergillus oryzae, Aspergillus nidulans, Penicillium chrysogenum and Acremonium chrysogenum. 4. A process as claimed in any one of claims 1 to 3 wherein said marker gene coding for nitrate reductase is contained in a plasmid selected from pSTA 1 (NCIMB 40102) pSTAIO, pSTA 14 and pSTA 700 (NCIMB 40103). 5. A process as claimed in any one of claims 1 to 4 wherein the niaD- cells are antibiotic producing strains of P.chrysogenum or A.chrysogenum or nitrate reductase deficient mutants thereof. S U BSTITUTE SHEET 6. A process as claimed in claim 5 wherein the niaD- cells are selected from P.chrysogenum strain S1900 (CMICC 330177) and A. chrysogenum strain M1160 (CMICC 330178) . 7. A process as claimed in any one of claims 1 to 6 further comprising introducing into said niaD- cells an industrially important gene in such a manner that both said gene and the nitrate reductase gene are expressed. 8. A process as claimed in claim 7 wherein said industrially important gene is selected from genes involved in antibiotic biosynthesis, genes which result in improved growth of the cells, genes which enable growth of the cells on a novel substrate and genes which will change the metabolite produced. 9. A process as claimed in claim 7 wherein said gene is selected from genes encoding the enzymes ACV synthetase, isopenicillin N synthetase, deacetoxycephalosporin C synthetase or PAC acetyl transferase. 10. A process as claimed in any one of claims 7 to 9 wherein said marker gene encoding nitrate reductase and said industrially important gene are carried on the same vector. 11. A process as claimed in any one of claims 7 to 9 wherein said marker gene encoding nitrate reductase and said industrially important gene are carried on different vectors. 12. A method producing a penicillin or cephalosporin antibiotic which comprises culturing a transformed strain of P. chrysogenum or A. chrysogenum and isolating S UBSTITUTE SHEET the desired penicillin or cephalosporin from the culture medium, characterised in that the transformed strain, of P. chrysogenum or A. chrysogenum is prepared by a process according to any one of claims 1 to 11. 13. Vector DNA for the transformation of cells of P. chrysogenum or A. chrysogenum which are deficient in the expresion of nitrate reductase, which comprises a marker gene coding for nitrate reductase, operatively linked to a control sequence for expression of the said gene. 14. Vector DNA as claimed in claim 13 further comprising an industrially important gene linked in matching reading frame to said marker gene. 15. Vector DNA as claimed in claim 14 wherein said industrially important gene is selected from genes involved in antibiotic biosynthesis, genes which result in improved growth of the cells, genes which enable growth of the cells on a novel substrate and genes which will change the metabolite produced. 16. Vector PNA as claimed in any one of claims 13 to 15 wherein said marker gene coding for nitrate reductase is derived from cells of the same species as the intended transformation host. 17. Vector DNA as claimed in claim 13 being Plasmid pSTA 1 (NCIMB 40102) or Plasmid pSTA 700 (NCIMB 40103) . 18. A transformed strain of P. chrysogenum or A. chrysogenum containing vector PNA as claimed in any one of claims 13 to 17. 19. Penicillium chrysogenum strain S1900 (CMICC 330177) or Acremonium chrysogenum strain M1160 (CMICC 330178 ) S UBSTITUTESHEET

Inventors: BIRKETT JOHN ANTHONY, KINGHORN JAMES ROBERT, BIRKETT, JOHN, ANTHONY, KINGHORN, JAMES, ROBERT
Applicants: GLAXO GROUP LTD, GLAXO GROUP LIMITED
Application year: 1990
Main classification: C12N1
IPC codes: C12N1, C12N9, C12N15, C12Q1, C12R1